Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Avid Bioservices, Inc.

CIK 704562Updated Nov 16, 2026

Name history
PEREGRINE PHARMACEUTICALS INC · through Dec 26, 2017TECHNICLONE CORP/DE/ · through Jul 31, 2000TECHNICLONE INTERNATIONAL CORP · through Feb 11, 1997

CDMOP price & chart

Provider market data
Historical security

This listing closed Apr 14, 2021. Live provider charts are shown only for current listings.

About the company

Avid Bioservices is a dedicated CDMO focused on development and CGMP manufacturing of biologics. The Company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With more than 30 years of experience producing biologics, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the Company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com

8-K · 2025-02-05 · 0001140361-25-003108

Company description from the cited filing.

In the news

No coverage from other publishers is available.

Recent filings

  1. 15-12G filing

    15-12G · 2025-02-18 · 0001193125-25-028029

  2. SCHEDULE 13G/A - filed by Point72 Asset Management, L.P. regarding Avid Bioservices, Inc.

    SCHEDULE 13G/A · 2025-02-14 · 0000902664-25-001028

  3. 4 filing

    4 · 2025-02-07 · 0001683168-25-000864

  4. 4 filing

    4 · 2025-02-07 · 0001683168-25-000863

  5. 4 filing

    4 · 2025-02-07 · 0001683168-25-000862

Show 5 more recent filings
  1. 4 filing

    4 · 2025-02-07 · 0001683168-25-000861

  2. 4 filing

    4 · 2025-02-07 · 0001683168-25-000860

  3. 4 filing

    4 · 2025-02-07 · 0001683168-25-000859

  4. 4 filing

    4 · 2025-02-07 · 0001683168-25-000858

  5. 4 filing

    4 · 2025-02-07 · 0001683168-25-000857

Financials

FY 2024 · USD
Revenue139,911,000USD · FY 2024
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

Net income-140,753,000USD · FY 2024
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

Operating income-18,678,000USD · FY 2024
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

Diluted EPS-2.23USD per share · FY 2024
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2024FY 2023FY 2022FY 2021
ASSETS
AssetsUSD336,557,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

450,785,000
Source

10-K/A · 2024-04-24 · 0001683168-24-002656

As of 2023-01-31

429,843,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

265,510,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Property, Plant and Equipment, NetUSD186,514,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

164,410,000
Source

10-K/A · 2024-04-24 · 0001683168-24-002656

As of 2023-01-31

92,955,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

37,455,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD38,106,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

59,916,000
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

126,166,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

169,915,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD16,644,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

14,826,000
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

20,547,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

18,842,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Inventory, NetUSD30,375,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

45,102,000
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

26,062,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

11,871,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Assets, CurrentUSD104,002,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

132,343,000
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

180,023,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

207,804,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Prepaid Expense and Other Assets, CurrentUSD6,513,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

2,111,000
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

1,879,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

1,064,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Operating Lease, Right-of-Use AssetUSD41,157,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

34,463,000
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

36,806,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

18,691,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Other Assets, NoncurrentUSD4,884,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

4,402,000
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

4,627,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

1,210,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

LIABILITIES AND EQUITY
LiabilitiesUSD275,668,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

265,665,000
Source

10-K/A · 2024-04-24 · 0001683168-24-002656

As of 2023-01-31

255,317,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

187,774,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Stockholders’ equity:
Preferred Stock, Value, IssuedUSD0
Source

10-Q · 2024-12-10 · 0001683168-24-008620

As of 2024-10-31

0
Source

10-Q · 2024-04-24 · 0001683168-24-002662

As of 2024-01-31

0
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

0
Source

10-Q · 2022-03-08 · 0001683168-22-001520

As of 2022-01-31

Common Stock, Value, IssuedUSD64,000
Source

10-Q · 2024-12-10 · 0001683168-24-008620

As of 2024-10-31

62,000
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

62,000
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

61,000
Source

10-Q · 2021-09-08 · 0001683168-21-004164

As of 2021-07-31

Additional Paid in CapitalUSD632,696,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

615,841,000
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

605,841,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

637,534,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Retained Earnings (Accumulated Deficit)USD-571,871,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

-430,783,000
Source

10-K/A · 2024-04-24 · 0001683168-24-002656

As of 2023-01-31

-431,377,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

-559,859,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Stockholders' Equity Attributable to ParentUSD60,889,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

185,120,000
Source

10-K/A · 2024-04-24 · 0001683168-24-002656

As of 2023-01-31

174,526,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

77,736,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Liabilities and EquityUSD336,557,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

450,785,000
Source

10-K/A · 2024-04-24 · 0001683168-24-002656

As of 2023-01-31

429,843,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

265,510,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Current liabilities:
Liabilities, CurrentUSD70,566,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

228,308,000
Source

10-K/A · 2024-04-24 · 0001683168-24-002656

As of 2023-01-31

75,761,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

70,936,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Operating Lease, Liability, CurrentUSD1,354,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

3,024,000
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

2,969,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

1,355,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Accounts Payable, CurrentUSD20,667,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

36,392,000
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

9,504,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

9,257,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Operating Lease, Liability, NoncurrentUSD44,336,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

35,659,000
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

37,886,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

19,889,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Additional Financial Items
Long-term DebtUSD54,241,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

—43,453,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

—

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2024FY 2023FY 2022FY 2021
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD11,109,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—4,480,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

3,453,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Share-based Payment Arrangement, Noncash ExpenseUSD9,731,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—7,380,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

3,854,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD-1,654,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—1,705,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

10,236,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Increase (Decrease) in InventoriesUSD-13,533,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—14,191,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

988,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Increase (Decrease) in Accounts PayableUSD7,133,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—-943,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

-608,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Deferred Income Tax Expense (Benefit)USD113,823,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—-115,082,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

—
Net Cash Provided by (Used in) Operating ActivitiesUSD10,952,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—9,465,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

31,182,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD-31,805,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—-56,411,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

-9,864,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Payments to Acquire Property, Plant, and EquipmentUSD31,805,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—56,411,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

9,864,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD20,067,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—3,197,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

112,335,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD38,106,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

As of 2024-04-30

60,266,000
Source

10-Q · 2023-03-13 · 0001683168-23-001459

As of 2023-01-31

126,516,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

As of 2022-04-30

170,265,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

As of 2021-04-30

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD——1,670,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

5,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Income Taxes Paid, NetUSD15,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—64,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

—
Additional Financial Items
Amortization of Debt Issuance CostsUSD1,503,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

———
Deferred Other Tax Expense (Benefit)USD118,473,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

———
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD-227,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—-381,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

0
Source

10-Q · 2022-12-06 · 0001683168-22-008217

2021-05-01 to 2021-10-31

Gain (Loss) on Disposition of Other AssetsUSD———0
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Gain (Loss) on Termination of LeaseUSD——0
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

0
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

Gain (Loss) on Extinguishment of DebtUSD-1,865,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

———
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD———11,212,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD———0
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Income Tax Expense (Benefit)USD113,826,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—-115,011,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

0
Source

10-Q · 2023-03-13 · 0001683168-23-001459

2021-05-01 to 2022-01-31

Net Income (Loss) Attributable to ParentUSD-140,753,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—127,672,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

11,212,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Net Income (Loss) Available to Common Stockholders, BasicUSD-140,753,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

—127,672,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

3,318,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Operating ExpensesUSD25,996,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

———
Other Nonoperating Income (Expense)USD-3,912,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

———
Proceeds from Issuance of Common StockUSD——0
Source

10-K · 2023-06-21 · 0001683168-23-004329

2022-05-01 to 2023-04-30

32,141,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Proceeds from Stock Options ExercisedUSD——2,700,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

3,600,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2024FY 2023FY 2022FY 2021
Total RevenueUSD139,911,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

149,266,000
Source

10-K · 2023-06-21 · 0001683168-23-004329

2022-05-01 to 2023-04-30

119,597,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

95,868,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Cost of RevenueUSD132,593,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

117,786,000
Source

10-K · 2023-06-21 · 0001683168-23-004329

2022-05-01 to 2023-04-30

82,949,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

66,561,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Selling, General and Administrative ExpenseUSD25,996,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

27,879,000
Source

10-K · 2023-06-21 · 0001683168-23-004329

2022-05-01 to 2023-04-30

21,226,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

17,064,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Operating Income (Loss)USD-18,678,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

3,601,000
Source

10-K · 2023-06-21 · 0001683168-23-004329

2022-05-01 to 2023-04-30

15,422,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

12,243,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Other Nonoperating Income (Expense)USD-3,912,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

———
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD-26,927,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

1,590,000
Source

10-K/A · 2024-04-24 · 0001683168-24-002656

2022-05-01 to 2023-04-30

12,661,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

11,212,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Income Tax Expense (Benefit)USD113,826,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

1,331,000
Source

10-K/A · 2024-04-24 · 0001683168-24-002656

2022-05-01 to 2023-04-30

-115,011,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

0
Source

10-Q · 2023-03-13 · 0001683168-23-001459

2021-05-01 to 2022-01-31

Net Income (Loss) Attributable to ParentUSD-140,753,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

259,000
Source

10-K/A · 2024-04-24 · 0001683168-24-002656

2022-05-01 to 2023-04-30

127,672,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

11,212,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Earnings Per Share, BasicUSD per share-2.23
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

0
Source

10-K/A · 2024-04-24 · 0001683168-24-002656

2022-05-01 to 2023-04-30

2.08
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

0.06
Source

10-Q · 2021-12-07 · 0001683168-21-006162

2021-08-01 to 2021-10-31

Earnings Per Share, DilutedUSD per share-2.23
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

0
Source

10-K/A · 2024-04-24 · 0001683168-24-002656

2022-05-01 to 2023-04-30

1.84
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

0.06
Source

10-Q · 2021-12-07 · 0001683168-21-006162

2021-08-01 to 2021-10-31

Weighted Average Number of Shares Outstanding, Basicshares63,199,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

62,268,000
Source

10-K · 2023-06-21 · 0001683168-23-004329

2022-05-01 to 2023-04-30

61,484,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

58,222,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Weighted Average Number of Shares Outstanding, Dilutedshares63,199,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

63,782,000
Source

10-K · 2023-06-21 · 0001683168-23-004329

2022-05-01 to 2023-04-30

70,474,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

59,426,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Additional Financial Items
Costs and ExpensesUSD—27,879,000
Source

10-K · 2023-06-21 · 0001683168-23-004329

2022-05-01 to 2023-04-30

21,226,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

17,064,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Current Income Tax Expense (Benefit)USD3,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

———
Depreciation, Depletion and Amortization, NonproductionUSD11,100,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

7,200,000
Source

10-K · 2023-06-21 · 0001683168-23-004329

2022-05-01 to 2023-04-30

——
Gross ProfitUSD7,318,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

31,480,000
Source

10-K · 2023-06-21 · 0001683168-23-004329

2022-05-01 to 2023-04-30

36,648,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

29,307,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD———11,212,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD———0
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Interest and Other IncomeUSD———133,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Interest ExpenseUSD4,337,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

3,013,000
Source

10-K/A · 2024-04-24 · 0001683168-24-002656

2022-05-01 to 2023-04-30

2,680,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

1,164,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Net Income (Loss) Available to Common Stockholders, BasicUSD-140,753,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

259,000
Source

10-K/A · 2024-04-24 · 0001683168-24-002656

2022-05-01 to 2023-04-30

127,672,000
Source

10-K · 2022-06-29 · 0001683168-22-004704

2021-05-01 to 2022-04-30

3,318,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Operating ExpensesUSD25,996,000
Source

10-K · 2024-07-02 · 0001683168-24-004610

2023-05-01 to 2024-04-30

———
Preferred Stock Dividends, Income Statement ImpactUSD—0
Source

10-K · 2023-06-21 · 0001683168-23-004329

2022-05-01 to 2023-04-30

0
Source

10-K · 2023-06-21 · 0001683168-23-004329

2022-05-01 to 2023-04-30

3,439,000
Source

10-K · 2021-06-29 · 0001683168-21-002764

2020-05-01 to 2021-04-30

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

ef20042864_ex4-1.htm · 8-K · 2025-02-05

EX-4.1 4 ef20042864_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 Execution Version AVID BIOSERVICES, INC. AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of February 5, 2025 7.00% Convertible Senior Notes due 2029 FIRST SUPPLEMENTAL INDENTURE, dated as of February 5, 2025 (this “Supplemental Indenture”), among Avid Bioservices, Inc., a Delaware corporation (the “Company”), as issuer, and U.S. Bank Trust Company, National Association, a nation…

8-K · 2025-02-05 · 0001140361-25-003108

Read attachment ↗
ef20042864_ex99-1.htm · 8-K · 2025-02-05

EX-99.1 5 ef20042864_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners Acquisition of biologics Contract Development and Manufacturing Organisation Avid Bioservices now completed GHO and Ampersand’s deep experience in CDMO investing to support Avid’s next stage of rapid growth including expanded offerings, talent investment and greater geographic reach London, UK, Boston, MA and Tustin, CA…

8-K · 2025-02-05 · 0001140361-25-003108

Read attachment ↗
ef20042864_ex99-2.htm · 8-K · 2025-02-05

EX-99.2 6 ef20042864_ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger TUSTIN, Calif., February 5, 2025 - Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to …

8-K · 2025-02-05 · 0001140361-25-003108

Read attachment ↗
ef20042621_ex99-1.htm · 8-K · 2025-01-30

EX-99.1 2 ef20042621_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Avid Stockholders Approve Transaction with GHO and Ampersand Tustin, CA, January 30, 2025 - Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that Avid stockholders voted to app…

8-K · 2025-01-30 · 0001140361-25-002461

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.